ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,674,560 | +22.8% | 42,000 | +33.3% | 0.74% | +45.7% |
Q1 2024 | $2,177,595 | +104.3% | 31,500 | +3.6% | 0.51% | +129.0% |
Q2 2021 | $1,066,000 | -3.0% | 30,400 | 0.0% | 0.22% | -2.2% |
Q1 2021 | $1,099,000 | +24.5% | 30,400 | 0.0% | 0.23% | -2.6% |
Q4 2020 | $883,000 | -11.8% | 30,400 | -14.4% | 0.23% | -12.5% |
Q3 2020 | $1,001,000 | -12.8% | 35,500 | 0.0% | 0.26% | -9.6% |
Q2 2020 | $1,148,000 | -20.6% | 35,500 | 0.0% | 0.29% | -24.9% |
Q1 2020 | $1,446,000 | -33.9% | 35,500 | 0.0% | 0.39% | -44.0% |
Q4 2019 | $2,189,000 | -15.4% | 35,500 | 0.0% | 0.70% | -4.9% |
Q3 2019 | $2,587,000 | +25.9% | 35,500 | +42.0% | 0.73% | +27.7% |
Q2 2019 | $2,055,000 | +115.9% | 25,000 | +85.2% | 0.57% | +146.4% |
Q1 2019 | $952,000 | +24.4% | 13,500 | -20.6% | 0.23% | +25.9% |
Q4 2018 | $765,000 | -20.4% | 17,000 | 0.0% | 0.18% | -33.5% |
Q3 2018 | $961,000 | – | 17,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |